RGEN
Repligen Corporation
Company Overview
| Mkt Cap | $8.18B | Price | $142.82 |
| Volume | 662.96K | Change | -1.49% |
| P/E Ratio | -320.8 | Open | $144.64 |
| Revenue | $634.4M | Prev Close | $144.98 |
| Net Income | $-25.5M | 52W Range | $102.97 - $182.52 |
| Div Yield | N/A | Target | $184.76 |
| Overall | 45 | Value | 40 |
| Quality | 50 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyRepligen Corporation (RGEN) is a leading Healthcare company in the Medical Instruments & Supplies industry, currently trading at $142.82 with a market capitalization of $8.18 billion. The stock is trading in the middle of its 52-week range, demonstrating average quality indicators with a MarketXLS quality score of 50.
Today's trading session shows RGEN with a volume of 663K shares. The stock opened down 0.23% from yesterday's close of $144.98. Current analyst estimates project earnings of $1.67 per share for this year, with next year targeting $2.14.
RGEN demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including NVAX, BMRN, NBIX, GE, CRL.
Key investment considerations for RGEN include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 29.4%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 9, 2025 at 07:40 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RGEN | $142.82 | -1.5% | 662.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |